Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022

    Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022
    Date: 13 Jun, 2017              Type: Diagnostics              Pages: 122

    • Electronic Access - Single User License
      $1,200.00
    • CD-ROM Mail Delivery
      $1,300.00
    • Hard-copy Mail Delivery
      $1,300.00
    • Electronic Access - Multi User License
      $2,000.00

    Get Free 10% Customization in this Report
     

    Europe Breast Cancer Screening Market will be less than US$ 8 Billion by the end of year 2022. Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. So, most of the countries of Europe has adopted or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as breast cancer screening method in Europe. 


    Germany has the Highest Market Share in Breast Cancer Screening Market, but it will lose its Market Leader Position to United Kingdom in Future 

    Germany is the clear winner in the breast cancer screening market as it has huge women population, advanced healthcare infrastructure and government supported screening programs. Under the programs, all women age between 50-69 years are eligible for free breast cancer screening test in every two years. Under this program eligible woman gets a letter from the regional mammography program center to participate in the breast cancer screening program.


    Germany will maintain their Dominating Position in Europe Breast Cancer Ultrasound Screening Market

    Due to strong healthcare expending power and increasing breast cancer awareness among the women, Germany is forecast to hold its dominating place in Europe Breast Cancer Screening Market. Presently, Germany, Italy and Spain are steadily losing their market share on comparison to this all other countries such as United Kingdom, France, Switzerland, Norway and Netherlands ultrasound screening market share is expected to grow in the forecasting period 2017-2022.

    Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 8 countries: United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland 
     
    This
    122 page report with 120 Figures and 2 Tables provides a complete analysis of top 8 courtiers of Europe Breast Cancer Screening Market. All the 8 countries in the report have been studied from 7 viewpoints.

    •    Countries Breast Cancer Mammography Screening Population Scenario and Forecast 
        Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast 
        Countries Breast Cancer Mammography Screening Market and Forecast 
        Countries Breast Cancer MRI Screening Market and Forecast 
        Countries Breast Cancer Ultrasound Screening Market and Forecast 
        Countries Breast Cancer Screening Market and Forecast 
    •    Worldwide Breast Cancer Screening Market and Forecast 


    All the 8 Countries Studied in the Report are as Follows 

     
    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Netherlands
    7.    Norway
    8.    Switzerland

     

    1.    Executive Summary

    2.    Europe Screening Population Analysis
    2.1    Europe Breast Cancer Mammography Screening Population & Forecast

    2.2    Europe Breast Cancer MRI & Ultrasound Screening Population & Forecast

    3.    Europe Breast Cancer Screening Market Analysis
    3.1    Europe Breast Cancer Screening Market & Forecast
    3.1.1    Europe Breast Cancer Mammography Screening Market & Forecast
    3.1.2    Europe Breast Cancer MRI Screening Market & Forecast
    3.1.3    Europe Breast Cancer Ultrasound Screening Market & Forecast

    4.    Europe Breast Cancer Screening Population & Market Share Analysis
    4.1    Europe Breast Cancer Mammography Screening Population Share & Forecast

    4.2    Europe Breast Cancer MRI & Ultrasound Screening Population Share & Forecast

    5.    Europe Breast Cancer Screening Market Share Analysis
    5.1    Worldwide Breast Cancer Screening Market Share & Forecast

    5.2    Europe Breast Cancer Mammography Screening Market Share & Forecast

    5.3    Europe Breast Cancer MRI Screening Market Share & Forecast

    5.4    Europe Breast Cancer Ultrasound Screening Market Share & Forecast

    6.    United Kingdom
    6.1    United Kingdom Breast Cancer Mammography Screening Population & Forecast

    6.2    United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    6.3    United Kingdom Breast Cancer Screening Market & Forecast
    6.3.1    United Kingdom Breast Cancer Mammography Screening Market & Forecast
    6.3.2    United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    6.3.3    United Kingdom Breast Cancer Ultrasound Screening Market & Forecast

    7.    France
    7.1    France Breast Cancer Mammography Screening Population & Forecast

    7.2    France Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    7.3    France Breast Cancer Screening Market & Forecast
    7.3.1    France Breast Cancer Mammography Screening Market & Forecast
    7.3.2    France Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    7.3.3    France Breast Cancer Ultrasound Screening Market & Forecast

    8.    Germany
    8.1    Germany Breast Cancer Mammography Screening Population & Forecast

    8.2    Germany Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    8.3    Germany Breast Cancer Screening Market & Forecast
    8.3.1    Germany Breast Cancer Mammography Screening Market & Forecast
    8.3.2    Germany Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    8.3.3    Germany Breast Cancer Ultrasound Screening Market & Forecast

    9.    Italy
    9.1    Italy Breast Cancer Mammography Screening Population & Forecast

    9.2    Italy Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    9.3    Italy Breast Cancer Screening Market & Forecast
    9.3.1    Italy Breast Cancer Mammography Screening Market & Forecast
    9.3.2    Italy Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    9.3.3    Italy Breast Cancer Ultrasound Screening Market & Forecast

    10.    Spain
    10.1    Spain Breast Cancer Mammography Screening Population & Forecast

    10.2    Spain Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    10.3    Spain Breast Cancer Screening Market & Forecast
    10.3.1    Spain Breast Cancer Mammography Screening Market & Forecast

    10.3.2    Spain Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast

    10.3.3    Spain Breast Cancer Ultrasound Screening Market & Forecast

    11.    Switzerland
    11.1    Switzerland Breast Cancer Mammography Screening Population & Forecast

    11.2    Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    11.3    Switzerland Breast Cancer Screening Market & Forecast
    11.3.1    Switzerland Breast Cancer Mammography Screening Market & Forecast
    11.3.2    Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    11.3.3    Switzerland Breast Cancer Ultrasound Screening Market & Forecast

    12.    Norway
    12.1    Norway Breast Cancer Mammography Screening Population & Forecast

    12.2    Norway Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    12.3    Norway Breast Cancer Screening Market & Forecast
    12.3.1    Norway Breast Cancer Mammography Screening Market & Forecast
    12.3.2    Norway Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    12.3.3    Norway Breast Cancer Ultrasound Screening Market & Forecast

    13.    Netherlands
    13.1    Netherlands Breast Cancer Mammography Screening Population & Forecast

    13.2    Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    13.3    Netherlands Breast Cancer Screening Market & Forecast
    13.3.1    Netherlands Breast Cancer Mammography Screening Market & Forecast
    13.3.2    Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
    13.3.3    Netherlands Breast Cancer Ultrasound Screening Market & Forecast

    14.    Europe Breast Cancer Screening Market - Growth Drivers
    14.1    Increasing Breast Cancer Care Awareness Initiatives

    14.2    Increasing Breast Cancer Cases

    15.    Breast Cancer Screening Market Challenges
    15.1    Difference of Opinion on Breast Cancer Mammography Screening

     

     

    List of Figures:

    Figure 2 1: Europe – Breast Cancer Mammography Screening Population (Million), 2010 – 2016
    Figure 2 2: Europe – Forecast for Breast Cancer Mammography Screening Population (Million), 2017 – 2022
    Figure 2 3: Europe – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 2 4: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022

    Figure 3 1: Europe – Breast Cancer Screening Market (Billion US$), 2010 – 2016
    Figure 3 2: Europe – Forecast for Breast Cancer Screening Market (Billion US$), 2017 – 2022
    Figure 3 3: Europe – Breast Cancer Mammography Screening Market (Billion US$), 2010 – 2016
    Figure 3 4: Europe – Forecast for Breast Cancer Mammography Screening Market (Billion US$), 2017 – 2022
    Figure 3 5: Europe – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 3 6: Europe – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 3 7: Europe – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 3 8: Europe – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 4 1: Europe – Breast Cancer Mammography Screening Population Share (Percent), 2010 – 2016
    Figure 4 2: Europe – Forecast for Breast Cancer Mammography Screening Population Share (Percent), 2017 – 2022
    Figure 4 3: Europe – Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2010 – 2016
    Figure 4 4: Europe – Forecast for Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2017 – 2022

    Figure 5 1: Europe – Breast Cancer Screening Market Share (Percent), 2010 – 2016
    Figure 5 2: Europe – Forecast for Breast Cancer Screening Market Share (Percent), 2017 – 2022
    Figure 5 3: Europe – Breast Cancer Mammography Screening Market Share (Percent), 2010 – 2016
    Figure 5 4: Europe – Forecast for Breast Cancer Mammography Screening Market Share (Percent), 2017 – 2022
    Figure 5 5: Europe – Breast Cancer MRI Screening Market Share (Percent), 2010 – 2016
    Figure 5 6: Europe – Forecast for Breast Cancer MRI Screening Market Share (Percent), 2017 – 2022
    Figure 5 7: Europe – Breast Cancer Ultrasound Screening Market Share (Percent), 2010 – 2016
    Figure 5 8: Europe – Forecast for Breast Cancer Ultrasound Screening Market Share (Percent), 2017 – 2022

    Figure 6 1: United Kingdom – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 6 2: United Kingdom – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 6 3: United Kingdom – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 6 4: United Kingdom – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 6 5: United Kingdom – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 6 6: United Kingdom – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 6 7: United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 6 8: United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 6 9: United Kingdom – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 6 10: United Kingdom – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 6 11: United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 6 12: United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 7 1: France – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 7 2: France – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 7 3: France – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 7 4: France – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 7 5: France – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 7 6: France – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 7 7: France – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 7 8: France – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 7 9: France – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 7 10: France – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 7 11: France – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 7 12: France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 8 1: Germany – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 8 2: Germany – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 8 3: Germany – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 8 4: Germany – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 8 5: Germany – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 8 6: Germany – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 8 7: Germany – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 8 8: Germany – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 8 9: Germany – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 8 10: Germany – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 8 11: Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 8 12: Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 9 1: Italy – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 9 2: Italy – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 9 3: Italy – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 9 4: Italy – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 9 5: Italy – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 9 6: Italy – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 9 7: Italy – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 9 8: Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 9 9: Italy – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 9 10: Italy – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 9 11: Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 9 12: Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 10 1: Spain – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 10 2: Spain – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 10 3: Spain – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 10 4: Spain – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 10 5: Spain – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 10 6: Spain – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 10 7: Spain – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 10 8: Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 10 9: Spain – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 10 10: Spain – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 10 11: Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 10 12: Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 11 1: Switzerland – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 11 2: Switzerland – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 11 3: Switzerland – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 11 4: Switzerland – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 11 5: Switzerland – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 11 6: Switzerland – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 11 7: Switzerland – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 11 8: Switzerland – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 11 9: Switzerland – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 11 10: Switzerland – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 11 11: Switzerland – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 11 12: Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 12 1: Norway – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 12 2: Norway – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 12 3: Norway – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 12 4: Norway – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 12 5: Norway – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 12 6: Norway – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 12 7: Norway – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 12 8: Norway – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 12 9: Norway – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 12 10: Norway – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 12 11: Norway – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 12 12: Norway – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 13 1: Netherlands – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 13 2: Netherlands – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 13 3: Netherlands – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 13 4: Netherlands – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 13 5: Netherlands – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 13 6: Netherlands – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 13 7: Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 13 8: Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 13 9: Netherlands – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 13 10: Netherlands – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 13 11: Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 13 12: Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022


    List of Tables:

    Table 26–1: Worldwide – Breast cancer Incidence Rate (Number), 2008 & 2012
    Table 26–2: Worldwide – Breast cancer Mortality Rate (Number), 2012

     


    Related Products